133 related articles for article (PubMed ID: 7692442)
21. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice.
Wicker LS; Miller BJ; Mullen Y
Diabetes; 1986 Aug; 35(8):855-60. PubMed ID: 3525284
[TBL] [Abstract][Full Text] [Related]
22. Targeting of pancreatic islets of severe combined immunodeficient mice by passive transfer of allogeneic spleen cells from non-obese diabetic mice.
Reddy S; Liu W; Elliott RB
Immunol Cell Biol; 1994 Oct; 72(5):390-7. PubMed ID: 7835983
[TBL] [Abstract][Full Text] [Related]
23. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
Lejon K; Fathman CG
J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
[TBL] [Abstract][Full Text] [Related]
24. Triptolide ameliorates autoimmune diabetes and prolongs islet graft survival in nonobese diabetic mice.
Huang SH; Lin GJ; Chu CH; Yu JC; Chen TW; Chen YW; Chien MW; Chu CC; Sytwu HK
Pancreas; 2013 Apr; 42(3):442-51. PubMed ID: 23146919
[TBL] [Abstract][Full Text] [Related]
25. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic islet beta cells drive T cell-immune responses in the nonobese diabetic mouse model.
Larger E; Bécourt C; Bach JF; Boitard C
J Exp Med; 1995 May; 181(5):1635-42. PubMed ID: 7722443
[TBL] [Abstract][Full Text] [Related]
27. Immunomodulation through inhibition of multiple adhesion molecules generates resistance to autoimmune diabetes in NOD mice.
Ninova D; Dean PG; Stegall MD
J Autoimmun; 2004 Nov; 23(3):201-9. PubMed ID: 15501391
[TBL] [Abstract][Full Text] [Related]
28. 15-Deoxyspergualin inhibits nitric oxide production in the BB/W rat: mechanism for inhibition of islet cell dysfunction in diabetes and transplantation.
Stevens RB; Lokeh A; Ansite JD; Rossini TJ; Sutherland DE; Mills CD
Transplant Proc; 1994 Dec; 26(6):3370. PubMed ID: 7527968
[No Abstract] [Full Text] [Related]
29. Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice.
Pacheco-Silva A; Bastos MG; Muggia RA; Pankewycz O; Nichols J; Murphy JR; Strom TB; Rubin-Kelley VE
Eur J Immunol; 1992 Mar; 22(3):697-702. PubMed ID: 1547815
[TBL] [Abstract][Full Text] [Related]
30. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content.
Füchtenbusch M; Larger E; Thebault K; Boitard C
Horm Metab Res; 2005 Feb; 37(2):63-7. PubMed ID: 15778920
[TBL] [Abstract][Full Text] [Related]
31. A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice.
Stosic-Grujicic S; Cvetkovic I; Mangano K; Fresta M; Maksimovic-Ivanic D; Harhaji L; Popadic D; Momcilovic M; Miljkovic D; Kim J; Al-Abed Y; Nicoletti F
J Pharmacol Exp Ther; 2007 Mar; 320(3):1038-49. PubMed ID: 17148780
[TBL] [Abstract][Full Text] [Related]
32. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice.
Qin HY; Sadelain MW; Hitchon C; Lauzon J; Singh B
J Immunol; 1993 Mar; 150(5):2072-80. PubMed ID: 8436836
[TBL] [Abstract][Full Text] [Related]
33. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes.
Kägi D; Ho A; Odermatt B; Zakarian A; Ohashi PS; Mak TW
J Immunol; 1999 Apr; 162(8):4598-605. PubMed ID: 10201999
[TBL] [Abstract][Full Text] [Related]
34. Active suppression of diabetes after oral administration of insulin is determined by antigen dosage.
Bergerot I; Fabien N; Mayer A; Thivolet C
Ann N Y Acad Sci; 1996 Feb; 778():362-7. PubMed ID: 8610991
[TBL] [Abstract][Full Text] [Related]
35. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
Reddy S; Young M; Poole CA; Ross JM
Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
[TBL] [Abstract][Full Text] [Related]
36. Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice.
Peterson JD; Pike B; McDuffie M; Haskins K
J Immunol; 1994 Sep; 153(6):2800-6. PubMed ID: 8077683
[TBL] [Abstract][Full Text] [Related]
37. Administration of IL-1 trap prolongs survival of transplanted pancreatic islets to type 1 diabetic NOD mice.
Rydgren T; Öster E; Sandberg M; Sandler S
Cytokine; 2013 Aug; 63(2):123-9. PubMed ID: 23664771
[TBL] [Abstract][Full Text] [Related]
38. Mucosal addressin is required for the development of diabetes in nonobese diabetic mice.
Hänninen A; Jaakkola I; Jalkanen S
J Immunol; 1998 Jun; 160(12):6018-25. PubMed ID: 9637517
[TBL] [Abstract][Full Text] [Related]
39. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
Moritani M; Yoshimoto K; Wong SF; Tanaka C; Yamaoka T; Sano T; Komagata Y; Miyazaki J; Kikutani H; Itakura M
J Clin Invest; 1998 Aug; 102(3):499-506. PubMed ID: 9691086
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase.
Welsh N; Eizirik DL; Bendtzen K; Sandler S
Endocrinology; 1991 Dec; 129(6):3167-73. PubMed ID: 1720090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
